share_log

Today's biggest pre-market stock movers: vTv Therapeutics, Aehr Test Systems, Unique Fabricating and more

Today's biggest pre-market stock movers: vTv Therapeutics, Aehr Test Systems, Unique Fabricating and more

當今最大的市場前股票推動者：vTV 治療，Aehr 測試系統，獨特的製造等
Benzinga Real-time News ·  2021/09/24 08:15  · 異動

Gainers

贏家

  • $vTv Therapeutics Inc(VTVT.US)$rose 21.47% to $2.15 in pre-market trading after the company disclosed results of multiple ascending dose studies and a development plan for HPP737, an oral PDE4 inhibitor for the treatment of psoriasis.

  • $Aehr Test Systems(AEHR.US)$ rose 21.4% to $14.30 in pre-market trading after the company reported better-than-expected Q1 results. The company also said it sees FY21 revenue of $50 million.

  • $Unique Fabricating Inc(UFAB.US)$ rose 19.4% to $3.01 in pre-market trading. The company’s Director Patrick W Cavanagh acquired a total of 13333 shares at an average price of $2.25.

  • $Progress Software Corp(PRGS.US)$ rose 15.3% to $53.30 in pre-market trading as the company reported better-than-expected results for its third quarter and raised FY21 guidance. The company also announced the acquisition of privately held Kemp for $258 million in cash.

  • $Minerva Neurosciences Inc(NERV.US)$ rose 13.6% to $2.09 in pre-market trading after gaining around 10% on Thursday.

  • $The Cross-Harbour(Holdings)(00032.HK)$ shares rose 8.1% to $0.7995 in pre-market trading after gaining around 4% on Thursday.

  • $Novo Integrated Sciences Inc(NVOS.US)$ rose 7.3% to $2.06 in pre-market trading after declining around 8% on Thursday.

  • $Argo Blockchain(ARBK.US)$ rose 6.6% to $17.86 in pre-market trading. The company’s shares jumped around 12% on Thursday after the company priced its IPO at $15 per ADS.

  • $Huaneng Power(HNP.US)$ rose 6.3% to $23.30 in pre-market trading.

  • $ReWalk Robotics Ltd(RWLK.US)$ rose 5.5% to $2.29 in pre-market trading after jumping over 21% on Thursday.

  • $ChemoCentryx Inc(CCXI.US)$ rose 5.2% to $18.90 in pre-market trading after climbing around 5% in the previous session. ChemoCentryx, last month, reported a Q3 loss of $0.56 per share.

  • $VTV治療公司(VTVT.US)$在盤前交易中，該公司股價上漲21.47%，至2.15美元，此前該公司披露了多次遞增劑量研究的結果，以及治療牛皮癬的口服PDE4抑制劑HPP737的開發計劃。

  • $Aehr測試系統(AEHR.US)$在盤前交易中，該公司股價上漲21.4%，至14.30美元，此前該公司公佈的第一季度業績好於預期。該公司還表示，預計21財年收入將達到5000萬美元。

  • $Unique Facing Inc.(UFAB.US)$在盤前交易中，該股上漲19.4%，至3.01美元。該公司董事帕特裡克·W·卡瓦納以2.25美元的平均價格收購了總計13333股。

  • $Progress Software Corp(PRGS.US)$在盤前交易中，該公司股價上漲15.3%，至53.30美元，該公司公佈的第三季度業績好於預期，並上調了21財年業績指引。該公司還宣佈以2.58億美元現金收購私人持股的Kemp。

  • $Minerva神經科學公司(NERV.US)$ 在週四上漲約10%後，該股在盤前交易中上漲13.6%，至2.09美元。

  • $香港海底隧道(控股)(00032.HK)$ 股價在週四上漲約4%後，在盤前交易中上漲8.1%，至0.7995美元。

  • $Novo集成科學公司(NVOS.US)$在週四下跌約8%後，該股在盤前交易中上漲7.3%，至2.06美元。

  • $Argo區塊鏈(ARBK.US)$在盤前交易中，該股上漲6.6%，至17.86美元。週四，在該公司將IPO定價為每股廣告15美元后，該公司股價上漲了約12%。

  • $華能電力(HNP.US)$ 在盤前交易中，該公司股價上漲6.3%，至23.30美元。

  • $ReWalk Robotics Ltd(RWLK.US)$在週四躍升逾21%後，該股在盤前交易中上漲5.5%，至2.29美元。

  • $ChemoCentryx Inc.(CCXI.US)$在盤前交易中，該公司股價上漲5.2%，至18.90美元，前一交易日攀升約5%。上個月，ChemoCentryx公佈第三季度每股虧損0.56美元。

Losers

失敗者

  • $HELBIZ INC(HLBZ.US)$ shares fell 12.1% to $20.21 in pre-market trading. Helbiz recently announced a partnership with Drover AI to integrate its PathPilot safety technology onto Helbiz e-scooters.

  • $InnSuites Hospitality Trust(IHT.US)$ fell 12.1% to $4.50 in pre-market trading after jumping over 45% on Thursday.

  • $Four Seasons Education(FEDU.US)$ fell 11.9% to $0.7310 in pre-market trading. Four Seasons Education shares climbed 43% on Thursday after the company announced board authorization to repurchase up to $15 million.

  • $Onconova Therapeutics Inc(ONTX.US)$ shares fell 11% to $4.55 in pre-market trading after the company reported a proposed public offering of common stock.

  • $MEDIROM Healthcare Technologies, Inc.(MRM.US)$ fell 9.8% to $11.54 in pre-market trading. MEDIROM Healthcare Technologies shares surged over 73% on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.

  • $Amplitude Healthcare Acquisition Corp(AMHC.US)$ shares fell 7.4% to $13.30 in pre-market trading after climbing over 40% on Thursday. The company announced shareholders approved the business combination with Jasper Therapeutics.

  • $Senmiao Technology(AIHS.US)$ shares fell 7.4% to $0.7650 in pre-market trading after jumping over 16% on Thursday.

  • $Transcode Therapeutics(RNAZ.US)$ fell 6.7% to $3.75 in pre-market trading. TransCode Therapeutics shares surged 53% on Thursday after the company announced that preclinical research supporting its lead candidate, TTX-MC138, was published in Cancer Nanotechnology.

  • $Valneva SE(VALN.US)$ fell 6.5% to $31.69 in pre-market trading. Valneva said it commenced recruitment of adolescents in its pivotal Phase 3 trial for its inactivated COVID-19 vaccine candidate VLA2001 in the U.K.

  • $Nike(NKE.US)$ fell 4.7% to $152.13 in pre-market trading. Nike reported better-than-expected earnings for its first quarter, while sales missed expectations. The company also lowered its sales forecast for the full year.

  • $HELBIZ Inc.(HLBZ.US)$在盤前交易中，該公司股價下跌12.1%，至20.21美元。Helbiz最近宣佈與Drover AI合作，將其PathPilot安全技術集成到Helbiz電動滑板車上。

  • $InnSuites酒店信託基金(IHT.US)$ 在週四躍升逾45%後，該股在盤前交易中下跌12.1%，至4.50美元。

  • $四季教育(FEDU.US)$在盤前交易中，該公司股價下跌11.9%，至0.7310美元。四季教育股價週四攀升43%，此前該公司宣佈董事會授權回購至多1,500萬美元。

  • $Onconova Treateutics Inc.(ONTX.US)$在盤前交易中，該公司股價下跌11%，至4.55美元，此前該公司公佈擬公開發行普通股。

  • $MEDIROM Healthcare Technologies，Inc.(MRM.US)$在盤前交易中，該公司股價下跌9.8%，至11.54美元。週四，在MEDIROM Healthcare Technologies將以336.2萬美元收購ZACC Kabushiki Kaisha的消息傳出後，該公司股價飆升逾73%。

  • $Amplance Healthcare Acquisition Corp(AMHC.US)$在週四攀升逾40%後，蘋果股價在盤前交易中下跌7.4%，至13.30美元。該公司宣佈，股東批准了與Jasper治療公司的業務合併。

  • $森妙科技(AIHS.US)$該公司股價在週四躍升逾16%後，在盤前交易中下跌7.4%，至0.7650美元。

  • $轉碼治療公司(RNAZ.US)$ 在盤前交易中下跌6.7%，至3.75美元。週四，Transcode治療公司股價飆升53%，此前該公司宣佈，支持其主要候選藥物TTX-MC138的臨床前研究發表在《癌症納米技術》雜誌上。

  • $Valneva SE(VALN.US)$ 在盤前交易中下跌6.5%，至31.69美元。Valneva說，它在英國開始為其滅活新冠肺炎候選疫苗VLA2001招募青少年，這是其關鍵的第三階段試驗。

  • $耐克(NKE.US)$在盤前交易中，該公司股價下跌4.7%，至152.13美元。耐克公佈的第一季度收益好於預期，而銷售額低於預期。該公司還下調了全年的銷售預期。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論